The Italian version of the “frailty index” based on deficits in health: a validation study by Abete, Pasquale et al.
Vol.:(0123456789) 
Aging Clin Exp Res (2017) 29:913–926 
DOI 10.1007/s40520-017-0793-9
ORIGINAL ARTICLE
The Italian version of the “frailty index” based on deficits 
in health: a validation study
Pasquale Abete1 · Claudia Basile1 · Giulia Bulli1 · Francesco Curcio1 · 
Ilaria Liguori1 · David Della‑Morte2,3 · Gaetano Gargiulo1,4 · Assunta Langellotto1,5 · 
Gianluca Testa1,6 · Gianluigi Galizia1,7 · Domenico Bonaduce1 · Francesco Cacciatore1 
Received: 22 June 2016 / Accepted: 29 September 2016 / Published online: 7 July 2017 
© Springer International Publishing AG 2017
Result At the end of follow-up, mortality increased from 
1.0 to 30.3%, disability from 40.9 to 92.3% and hospitaliza-
tion from 0.0 to 59.0% (p < 0.001 for trend). Multivariate 
analysis shows that the relative risk for unit increase in IFi 
is 1.09 (95% CI = 1.01–1.17, p = 0.013) for mortality, 1.04 
(95% CI  =  1.01–1.06, p  =  0.024) for disability and 1.03 
(95% CI = 1.01–1.07, p = 0.041) for hospitalization. AUC 
is higher in IFi with respect to Fried’s frailty index when 
considering mortality (0.809 vs. 0.658, respectively), dis-
ability (0.800 vs. 0.729, respectively) and hospitalization 
(0.707 vs. 0.646, respectively).
Conclusions IFi is a valid measure of frailty after the 
comprehensive geriatric assessment in an Italian cohort of 
non-institutionalized patients.
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Introduction
There is strong evidence that frailty may become one of 
most relevant problems in public health. A global epi-
demiological transition is currently occurring, in which 
mortality is becoming more likely to be a consequence of 
age-related degenerative diseases with respect to infectious 
diseases [1]. In fact, age-related chronic diseases are largely 
prevalent in frailty leading to serious functional limitations 
and susceptibility to adverse outcomes. Since older people 
have been considerably raised in all countries, frailty preva-
lence is expected to dramatically increase [2].
Frailty does not yet have an established standard 
definition. However, frailty is considered as a geriatric 
dynamic condition characterized by an increased vulner-
ability to external stressors, by a multi-system dysfunc-
tion, by a complex etiology and by an intrinsic difficulty in 
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distinguishing from aging [3, 4]. Frailty is currently con-
sidered as “primary” or “preclinical” when the state is not 
associated directly with a specific disease, or when there 
is no substantial disability. Accordingly, the presence of 
three or more of the five Fried criteria is used for recog-
nizing preclinical frailty (unintentional weight loss, exhaus-
tion, low energy expenditure, slowness and weakness) [5]. 
In contrast, frailty is considered “secondary” or “clinical” 
when it is associated with known comorbidity and/or dis-
ability [6, 7]. The characteristics of clinical frailty include 
not only comorbidity and disability, but also polypharmacy 
and relative adverse drug reactions, hospitalization, health 
services utilization, age-associated sensory deficits and 
lack of social support [6, 7]. This condition is associated 
with higher long-term mortality alone and chronic disease 
as chronic heart failure [7–9].
How best to measure frailty is still controversial [10–12]. 
Several scores were computed for frailty classification 
and prognosis across a broad range of medical patients, 
including Fried’s frailty phenotype and the “frailty index.” 
“Frailty index” is based on “deficits in health” including 
symptoms, signs, diseases, disabilities or laboratory, radi-
ographic or electrocardiographic abnormalities. Several 
groups have utilized the “frailty index” with different num-
ber of deficits, but the higher deficit count is always related 
to the larger number of adverse outcomes including death, 
disability and institutionalization [13–16].
To the best of our knowledge, the “frailty index” is still 
not available in Italian version. Thus, the aim of the pre-
sent work was to prepare and validate a version of “frailty 
index” for the Italian geriatric community.
Methods
Study sample
The validation of Italian frailty index is based on a cohort 
study in Campania, a region of South Italy that enrolled 
individuals aged 65 years or older. Briefly, 1077 non-disa-
bled outpatients, Italian speaking, with life expectancy and 
plans to stay in the area for more than 24 months were con-
secutively enrolled in the study. The enrollment started in 
September 2009.
Comprehensive geriatric assessment (CGA)
Elderly subjects underwent a comprehensive geriatric mul-
tidimensional assessment which included: cognitive func-
tion evaluation with Mini-Mental State Examination [17]; 
depressive symptoms with Geriatric Depression Scale 
[18]; comorbidity severity with a Cumulative Illness Rat-
ing Scale (CIRS-G) [19] and drug number; disability with 
Basic and Instrumental Activity of Daily Living [BADL 
and IADL] [20, 21]; nutritional assessment by Mini Nutri-
tional Assessment (MNA) [22]; equilibrium and risk of fall 
with the Tinetti Scale [23]; physical performance with 4-m 
gait speed [m/s] [24]; physical activity with Physical Activ-
ity Scale for the Elderly (PASE) [25]; and social support 
evaluation with Social Support Assessment scored from 17 
[subjects with the lowest support] to 0 (subjects with the 
highest support) (SSA) [26].
Italian frailty index (IFi)
The Italian frailty index (IFi) has been constructed by 
counting deficits in health, and it has been derived from 
a validated scale used in a cohort of New Haven (Con-
necticut, USA) in the Yale Precipitating Events Project 
study [27]. Briefly, these deficits were defined as symp-
toms, signs, disabilities and diseases. All health deficits 
include continuous, ordinal and binary variables. Dis-
ability in basic and instrumental activities of daily living 
including impaired grip strength and walking, comorbid-
ity, self-rated health, and depression was evaluated. Frailty 
index includes information on 40 deficits that are meas-
ured in routine assessments of older adults. Grip strength 
and shoulder strength were evaluated using a handheld 
dynamometer (Mecmesin Advanced Force Gauge 500  N, 
GDM, Corsico (MI) Italy). The peak expiratory flow is 
measured with a peak flow meter for adults (Neupharma 
Imola, BO, Italy). All binary variables were coded, using 
the “0” to indicate the absence and “1” the presence of 
deficit. For intermediate response, we used “0.25,” “0.5” 
and “0.75” (i.e., MMSE less than 10 = 1, 0.75 for scores 
≥10 and ≤17, 0.5 for scores ≥18 and ≤20, 0.25 for scores 
>20 and <24, indicating a grading of cognitive impairment 
from 1 = severe dementia to 0.25 = mild cognitive impair-
ment, and to 0  =  no dementia). In order to better define 
“socioeconomic” and “nutritional” frailty, with respect 
to original “frailty index,” the item #24 (feel lonely) and 
item #39 (usual pace) has been substituted in IFi by “social 
support score” (>13 = 1; 6–13 = 0.5 and 1–5 = 0) and by 
Mini Nutritional assessment (<17 = 1; 17–23.5 = 0.5 and 
24 = 0). The index has been expressed as a ratio of defi-
cits present to the total number of deficits considered: If 
40 deficits were considered, and 20 were present in a given 
person, frailty index would be 20/40 = 0.50.
Only 12 participants reported 0.00 to IFi and are there-
fore excluded from the study. Then, IFi has been subdivided 
into tertiles (0.0/16.0, 16.1/27.0 and 27.1/40.0). Thus, 1065 
participants were enrolled in the follow-up at 3, 6, 12 and 
24 months from the baseline, and 907 patients completed 
the study (84.2%).
The Fried’s frailty index was calculated by consider-
ing the following item of IFi: #9 (help lifting 10 lbs), #15 
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(lost more than 10 lbs in last year), #19 (cut down on usual 
activity in last month), #21 (feel everything is an effort) 
and #40 (4-m gait speed <10 s).
In Appendix 1 are reported the IFi, social support score 
and Mini Nutritional Assessment in Italian language.
Outcomes
Mortality, disability (considering an increase in ADL lost 
≥1 from the baseline) and hospitalization were considered 
at 3, 6, 12, 18 and 24 months of follow-up.
Ethics
The study protocol was approved by the University of 
Naples Federico II (Comitato Etico per le attività Biomedi-
che “Carlo Romano” prot. n.211/2013). All participants 
provided informed consent at baseline and at follow-up.
Statistics
Statistical analysis was performed using SPSS version 
23. Continuous and categorical variables are presented as 
mean ± standard deviations (SD) or as percentages, respec-
tively. ANOVA test with Bonferroni’s post hoc correction 
was performed to compare continuous variables across 
groups, and Chi-square test was used for categorical vari-
ables. Logistic regression was used to examine receiver 
operating characteristics (ROC) curves in order to compare 
the performance of IFi Fried’s frailty Index in predicting 
the outcomes. Area under curve (AUC) between 0.8 and 0.9 
was considered good [28]. Sample size for two ROC curves 
method has been utilized; AUC for Fried’s index  =  0.75 
and for IFi = 0.80, with a probability of type error α = 0.05 
and a power of the study (1−β) = 0.90, has been consid-
ered. Thus, 777 subjects are needed. To test inter-rater reli-
ability of the IFi using the kappa coefficient (κ) and assum-
ing that excellent agreement was indicated by a value of 
≥0.80, we calculated a requirement of 25 subjects. Cron-
bach’s value was employed to test internal reliability. Cox 
proportional hazards models were used to analyze the asso-
ciations between frailty status as defined according to the 
IFi indexes and subsequent outcomes, including mortal-
ity, disability and hospitalization. The relative risk of each 
outcome, with 95% confidence intervals, was estimated for 
IFi and for each item adjusted for age and sex. Cumulative 
survival according to Cox regression analysis adjusted for 
age and sex of mortality, disability (considering the loss of 
1 ADL vs. baseline) and hospitalization stratified in light, 
moderate and severe IFi was performed.
Results
The flowchart of the study with the final number of 
participants is shown in Fig.  1. The IFi showed a good 
inter-rater variability (κ = 0.84, p < 0.001; n = 25) and 
a good internal consistency (Cronbach’s value  =  0.83). 
Finally, in 25 participants, the time consumption of IFi 
was 40.2  ±  9.1  min. The time to administer IFi is rela-
tively short if the administration is made after CGA 
(9.5 ± 3.1 min; p < 0.001).
Demographic characteristics and CGA of the cohort 
are described in Table 1. Mean age is 81.3 ± 6.5 years, 
and 997 subjects have completed the follow-up (82.4%). 
Female are 56.7% (n = 611) with a parallel increase with 
frailty severity degree increase (from 44.2 to 65.0%, 
p < 0.001). As expected, CIRS and total drugs increase 
with frailty (from 1.7  ±  0.4 to 2.0  ±  0.4 and 5.8  ±  3.0 
to 6.7  ±  3.2, respectively; p for trend <0.001). ADL 
and IADL lost increase from 0.7 ± 1.4 to 3.5 ± 1.6 and 
from 1.9 ± 2.4 to 5.9 ± 2.2; p for trend <0.001). MMSE 
decreases, while GDS progressively increases with frailty 
Fig. 1  Flowchart of the study with the final number of participants
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increase, reaching a value of 18.5  ±  6.8 and 9.8  ±  4.0, 
respectively (p for trend <0.001). Nutritional index as 
BMI and MNA as well as Tinetti, 4-m gait speed and 
PASE score, progressively decrease as frailty degree 
increases. Interestingly, low social support progres-
sively decreases as frailty increases (from 6.1  ±  5.7 to 
10.1 ± 4.5, p for trend <0.001). Accordingly, IFi reaches 
30.4  ±  2.2, while Fried’s frailty index 4.7  ±  1.0 in the 
highest frailty degree.
In Table  2 are reported the percentage of the 40 dif-
ferent items in the cohort. As expected, the higher per-
centage in all 40 items are reached in the highest degree 
of frailty. In particular, a percentage greater than 90% 
in the highest frailty degree were the item 8 (help up/
down stairs  =  96.3%), the item 21 (feel everything is an 
effort = 95.7%) and the item 2 (help dressing = 94.3%).
In Fig.  2 are reported the prevalence of mortality, dis-
ability (considering the loss of 1 ADL vs. baseline) and the 
hospitalization. At the end of follow-up (24 months), mor-
tality was 13.0% in all subjects and progressively increases 
from 1.0 to 30.3% (p  <  0.001 for trend). Disability was 
68.2% in all subjects and progressively increases from 40.9 
to 92.3% (p < 0.001 for trend). Hospitalization was 35.3% 
in all subjects and progressively increases from 18.2 to 
59.0% (p < 0.001 for trend).
Multivariate analysis, adjusted for age and sex, shows 
that the relative risk for unit increase in IFi is 1.09 (95% 
confidence interval 1.01–1.17, p  =  0.013) for mortality, 
1.04 (95% confidence interval 1.01–1.06, p = 0.024) for 
disability and 1.03 (95% confidence interval 1.01–1.07, 
p = 0.041) for hospitalization (Fig. 3).
When IFi was separately analyzed for 40 items, dif-
ferent values of relative risk were found for the three 
outcomes and statistically significant items are reported 
in bold. For mortality, the most powerful value was 
the item 21 (feel everything is an effort  =  RR 4.83, CI 
95% 1.32–17.5; p = 0.02), for disability was the item 29 
(stroke = RR 2.29, CI 95% 1.24–4.23; p < 0.01) and for 
hospitalization was the item 22 (feel depressed  =  2.77; 
CI 95% 1.46–5.26; p < 0.01) (Table 3).
In Fig.  4 are represented the ROC curves of IFi and 
Fried’s frailty index. AUC is higher in IFi than Fried’s 
frailty index on mortality, disability and hospitalization.
Discussion
Our results indicate that IFi is a valid measure of frailty 
after the comprehensive geriatric assessment in an Italian 
cohort of non-institutionalized patients. IFi has a good 
reliability, an acceptable internal consistency and a good 
validity including all concept of frailty (mental, physical, 
social and nutritional).
Table 1  Demographic 
characteristics and 
comprehensive geriatric 
assessment of the sample
MNA Mini Nutritional Assessment (MNA), MMSE Mini-Mental State Examination, CIRS-G Cumulative 
Illness Rating Scale, BADL Basic Activity of Daily Living, IADL Instrumental Activity Daily Living, GDS 
Geriatric Depression Scale and PASE Physical Activity Scale for the Elderly
Variables Frailty p for trend
Light (n = 354, 32.9%) Moderate 
(n = 350, 32.5%)
Severe 
(n = 373, 
34.6%)
Age (years ± SD) 79.9 ± 6.6 81.8 ± 6.3 82.3 ± 6.3 0.001
Female sex (%) 44.2 62.0 65.0 0.001
Complete follow-up (%) 83.9 86.5 84.2 0.300
CIRS-G 1.7 ± 0.4 1.9 ± 0.4 2.0 ± 0.4 0.001
Total drugs 5.8 ± 3.0 5.9 ± 3.0 6.7 ± 3.2 0.025
MMSE 24.7 ± 4.7 22.2 ± 5.2 18.5 ± 6.8 0.001
GDS 4.5 ± 3.9 8.2 ± 3.9 9.8 ± 4.0 0.001
BADL lost 0.7 ± 1.4 1.8 ± 1.5 3.5 ± 1.6 0.001
IADL lost 1.9 ± 2.4 4.6 ± 2.1 5.9 ± 2.2 0.001
BMI 27.2 ± 4.9 27.7 ± 5.5 26.8 ± 8.1 0.160
MNA 23.5 ± 3.3 20.8 ± 3.5 18.0 ± 4.1 0.001
Tinetti score 23.1 ± 5.4 17.3 ± 5.8 11.2 ± 6.9 0.001
Social support score 6.1 ± 5.7 8.5 ± 4.4 10.1 ± 4.5 0.001
PASE 69.1 ± 58.4 32.2 ± 43.1 17.2 ± 38.4 0.001
Frailty index 10.3 ± 4.5 22.8 ± 2.9 30.4 ± 2.2 0.001
Fried’s frailty index 2.1 ± 1.3 3.8 ± 1.1 4.7 ± 1.0 0.001
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Frailty measurements: status of the art
Frailty measurements were utilized for frailty classifica-
tion and prognosis across a large range of medical patients, 
including geriatric, oncology, and surgical, orthopedic, car-
diovascular and renal patients. Among the most common 
frailty measurements, “Fried’s frailty” and “frailty index” 
are the most common frailty scores [12].
“Fried’s frailty” known as the Cardiovascular Health 
Study (CHS) Index [5] considers frailty by its physical 
characteristics, or “phenotype,” defining the condition as 
the presence of three or more of shrinking [5]. It has been 
Table 2  Items description with their percentage in all participants and stratified for light, moderate and severe frailty
Items Frailty P for trend
Light Moderate Severe
1. Help bathing (yes = 1/no = 0, %) 3.9 61.4 98 0.001
2. Help dressing (yes = 1/no = 0, %) 5 49.6 94.3 0.001
3. Help getting in/out of chair (yes = 1/no = 0, %) 3.7 33.1 81.9 0.001
4. Help walking around house (yes = 1/no = 0, %) 1.8 23.6 74.5 0.001
5. Help eating (yes = 1/no = 0, %) 1.6 21.6 70.5 0.001
6. Help grooming (yes = 1/no = 0, %) 32.3 89.6 98.6 0.001
7. Help using toilet (yes = 1/no = 0, %) 1 31.4 83.4 0.001
8. Help up/down stairs (yes = 1/no = 0, %) 8.1 70 96.3 0.001
9. Help lifting 10 lbs (yes = 1/no = 0, %) 20.2 72.3 89.4 0.001
10. Help shopping (yes = 1/no = 0, %) 24.1 93.4 91.4 0.001
11. Help with housework (yes = 1/no = 0, %) 34.4 89.6 92.3 0.001
12. Help with meal preparations (yes = 1/no = 0, %) 19.4 73.8 96.6 0.001
13. Help taking medication (yes = 1/no = 0, %) 15.2 61.4 89.1 0.001
14. Help with finances (yes = 1/no = 0, %) 11 64 88.3 0.001
15. Lost more than 10 lbs in last year (yes = 1/no = 0, %) 18.1 38.3 59.3 0.001
16. Self-rating of health (poor = 1/fair = 0.75/good = 0.5/very good = 0.25/excellent = 0,%) 9.7 47.6 67.3 0.01
17. Health has changed in last year (yes = 1/no = 0, %) 48.3 76.7 91.7 0.001
18. Stayed in bed at least half the day due to health (in last month) (yes = 1/no = 0,%) 22 38 64.5 0.001
19. Cut down on usual activity (in last month) (yes = 1/no = 0, %) 31 50.4 77.4 0.001
20. Walk outside (yes = 1/no = 0, %) 26 75.2 92.6 0.001
21. Feel everything is an effort (most of time = 1/sometime = 0.5/rarely = 0, %) 42.3 82.4 95.7 0.001
22. Feel depressed (most of time = 1/sometime = 0.5/rarely = 0, %) 11.5 52.2 71.1 0.001
23. Feel happy (most of time = 1/sometime = 0.5/rarely = 0, %) 9.4 45.8 70.5 0.001
24. Social support (> 13 = 1/6–13 = 0.5/1–5 = 0) 5.8 15.9 31.5 0.001
25. Have trouble getting going (most of time = 1/sometime = 0.5/rarely = 0, %) 8.7 44.4 77.9 0.001
26. High blood pressure (yes = 1/suspected = 0.5/no = 0, %) 70.3 79.8 86.5 0.01
27. Heart attack (yes = 1/suspected = 0.5/no = 0, %) 21.5 18.7 25.8 0.001
28. CHF (yes = 1/suspected = 0.5/no = 0, %) 14.4 21.6 26.4 0.001
29. Stroke (yes = 1/suspected = 0.5/no = 0, %) 3.9 11.2 12.3 0.001
30. Cancer (yes = 1/suspected = 0.5/no = 0, %) 8.7 12.7 23.8 0.001
31. Diabetes (yes = 1/suspected = 0.5/no = 0, %) 21.5 32 34.4 0.01
32. Arthritis (yes = 1/suspected = 0.5/no = 0, %) 38.3 65.4 75.1 0.001
33. Chronic lung disease (yes = 1/suspected = 0.5/no = 0, %) 20.2 33.7 44.1 0.001
34. MMSE (< 10 = 1/11–17 = 0.75/18-20 = 0.5/20–24 = 0.25/> 24 = 0) 62.5 60.5 71.9 0.001
35. BMI (< 18.5, ≥ 30 = 1/25– < 30 = 0.5/18.5–24.9 = 0) 15.5 28.8 37 0.001
36. Peak Expiratory Flow (yes = 1/no = 0, %) 56.4 85.9 88.3 0.001
37. Shoulder strength (yes = 1/no = 0, %) 26.2 64.8 82.5 0.001
38. Grip strength (yes = 1/no = 0, %) 46.2 79.3 88.3 0.001
39. Mini Nutritional Assessment (< 17 = 1/17–23.5 = 0.5/24 = 0) 7.3 21.3 48.1 0.001
40. Rapid pace (> 10 = 1/≤ 10 = 0) 13.9 53.6 78.2 0.001
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applied to multiple epidemiological studies where it is pre-
dictive of adverse clinical outcomes, including mortality 
[5, 29, 30]. Moreover, the frailty phenotype often has been 
modified, and these modifications have important impact 
on its classification and predictive ability [31]. Modified 
criteria of the frailty phenotype were evaluated by esti-
mating the prevalence and mortality by using the Survey 
of Health, Ageing and Retirement in Europe (SHARE). In 
this context, frailty prevalence ranged from 12.7 to 28.2%, 
agreement with the primary frailty phenotype ranged from 
0.662 to 0.967, internal consistency ranged from 0.430 to 
0.649, and AUC curves for discriminating five-year mor-
tality ranged from 0.607 to 0.668 [31]. Unfortunately, 
“Fried’s frailty” does not include psychosocial components 
of frailty.
The “frailty index” was based on accumulative defi-
cits and firstly proposed by Rockwood and Mitnitski as 
a technique to include the multidimensional nature of 
frailty into an operational definition [27, 32]. It involves 
the accumulation of symptoms, diseases, disabilities or 
any deficit in health supposing that a greater number of 
health deficits define a higher frailty [33]. Importantly, 
health and not age “per se” is related to frailty [33]. 
The “frailty index” is well validated and applied to sev-
eral study cohorts including the Survey of Health, Age-
ing and Retirement (SHARE). Moreover, several studies 
have demonstrated that the “frailty index” has a higher 
predictive ability of adverse clinical outcomes than other 
frailty measurements in both hospital and community 
settings [11, 33]. Interestingly, frailty index score rather 
than type of health deficits is most predictive of adverse 
events [6]. Despite its many positive characteristics. The 
“frailty index” has in the “time consuming” the greatest 
limitation [34, 35]. However, when derived from data 
already collected in a comprehensive geriatric assessment 
(CGA), the reliability becomes really consistent.
The Study of Osteoporotic Fractures (SOF) frailty 
index [36] defined frailty as the presence of ≥2 compo-
nents out of list of three: weight loss, exhaustion and low 
mobility, and it is an independent predictor of adverse 
outcomes in community-dwelling older people [37]. 
Unfortunately, this tool is not easily applicable because 
patients with an acute medical condition often cannot 
perform a five-times-chair-rise (low mobility) [38].
The Edmonton Frail Scale (EFS) [39] contains nine 
components (cognition; general health status, self-
reported health, functional independence, social support, 
polypharmacy, mood, continence and functional perfor-
mance) in 17 items. The EFS has been used to identify 
frailty in specific clinical populations [40] and in acute 
care [41, 42].
Fatigue, Resistance, Ambulation, Illness and Loss of 
Weight (FRAIL) includes five components: fatigue (self-
report), resistance, ambulation (slow walking speed), 
illness and loss of weight (5% or more in the past year) 
[43], and it has been found to be predictive of mortality 
in specific populations [44], but not in both hospitalized 
and community-dwelling older people.
Several other frailty instruments with different limita-
tions have been validated including the “Clinical Frailty 
Scale” (CFS) [45], the “Multidimensional Prognostic 
Instrument” (MPI) [46], the “Tilburg Frailty Indicator” 
(TFI) [47], the “PRISMA-7 P” [48], the “Groningen 
Frailty Indicator” (GFI) [49], the “Sherbrooke Postal 
Questionnaire” (SPQ) [50], the “Gérontopôle Frailty 
Screening Tool” (GFST) [51] and the “Kihon Checklist” 
(KCL) [52].
In our study, “frailty index” was modified in terms of 
nutritional and socioeconomic state. In fact, IFi includes 
both MNA [22] and Social Support Assessment [26]. This 
may explain why in our cohort IFi was more predictive 
than “frailty index” on mortality (Relative risk for unit of 
increase = 1.09 in IFi and 1.03 for “frailty index”) [27].
Fig. 2  Prevalence of mortality (a), disability (considering the loss of 
1 ADL vs. baseline) (b) and hospitalization (c) at the end of follow-
up (24 months) stratified in light, moderate and severe frailty index
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Fig. 3  Cumulative survival 
according to Cox regression 
analysis adjusted for age and sex 
of mortality (a), disability (con-
sidering the loss of 1 ADL vs. 
baseline) (b) and hospitalization 
(c) stratified in light, moderate 
and severe frailty index. RR 
Relative risk, CI confidence 
interval
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Comprehensive geriatric assessment before frailty 
measurements: is it the key point?
The frailty index derived from CGA is simply a frailty 
score deriving from a CGA. It is well known that CGA 
is the global standard clinical assessment for older peo-
ple, and includes medical, nutritional, functional, men-
tal and socioeconomic by a geriatric evaluation unit [53]. 
The CGA-frailty index was firstly performed in a ten-
domain index, with 14 CGA components included [54, 55]. 
Table 3  Relative risk and ranking weight of the 40 items of frailty index on mortality, disability (≥1 ADL lost) and hospitalization
RR Relative risk; CI confidence interval
Items Mortality Disability Hospitalization
RR CI 95% p RR CI 95% p RR CI 95% p
1. Help bathing 0.98 0.32–1.14 0.08 1.97 1.10–3.53 0.02 0.84 0.48–1.46 0.53
2. Help dressing 2.69 0.73–9.88 0.14 2.14 1.17–3.91 0.01 0.86 0.50–1.48 0.59
3. Help getting in/out of chair 2.82 1.20–6.62 0.02 2.05 1.17–3.61 0.01 1.53 0.99–.2.35 0.05
4. Help walking around house 2.07 0.95–4.49 0.07 0.85 0.44–1.61 0.61 1.22 0.78–1.91 0.39
5. Help eating 2.02 1.00–4.08 0.05 0.66 0.35–1.22 0.18 1.24 0.82–1.88 0.32
6. Help grooming 0.97 0.31–2.97 0.95 0.77 0.45–1.32 0.34 1.63 0.96–2.77 0.07
7. Help using toilet 1.78 0.81–3.93 0.15 1.75 0.99–3.09 0.06 1.63 1.06–2.49 0.03
8. Help up/down stairs 4.12 1.21–14.0 0.02 1.00 0.62–1.62 0.99 1.46 0.92–2.31 0.11
9. Help lifting 10 lbs 1.83 0.85–3.94 0.12 1.11 0.74–1.66 0.61 1.01 0.69–1.48 0.96
10. Help shopping 0.71 0.23–2.21 0.55 1.32 0.79–2.20 0.30 0.96 0.56–1.63 0.87
11. Help with housework 0.66 0.29–1.50 0.33 0.93 0.55–1.57 0.78 0.95 0.59–1.52 0.82
12. Help with meal preparations 0.96 0.38–2.47 0.94 0.92 0.57–1.49 0.74 0.76 0.49–1.19 0.23
13. Help taking medication 0.69 0.32–1.52 0.36 0.94 0.60–1.47 0.78 0.78 0.52–1.17 0.23
14. Help with finances 0.89 0.41–1.93 0.76 1.21 0.74–1.96 0.45 1.10 0.71–1.69 0.68
15. Lost more than 10 lbs in last year 2.28 1.31–3.94 0.00 1.12 0.77–1.62 0.55 1.36 1.00–1.86 0.05
16. Self-rating of health 0.12 0.03–0.56 0.01 0.54 0.23–1.27 0.16 0.72 0.31–1.64 0.43
17. Health has changed in last year 1.39 0.60–3.21 0.44 0.96 0.63–1.45 0.83 1.19 0.80–1.77 0.40
18. Stayed in bed at least half the day 
due to health
2.38 1.29–4.41 0.01 1.26 0.85–1.87 0.25 1.52 1.09–2.12 0.01
19. Cut down on usual activity 1.85 0.89–3.85 0.10 1.05 0.72–1.55 0.79 1.38 0.98–1.95 0.06
20. Walk outside 0.92 0.42–2.01 0.84 1.08 0.72–1.62 0.71 0.95 0.64–1.41 0.79
21. Feel everything is an effort 4.83 1.33–17.5 0.02 1.02 0.63–1.65 0.93 1.22 0.73–2.03 0.45
22. Feel depressed 0.77 0.26–2.24 0.63 1.29 0.63–2.66 0.49 2.77 1.46–5.26 0.01
23. Feel unhappy 0.56 0.20–1.60 0.28 0.73 0.36–1.48 0.38 0.43 0.23–0.80 0.01
24. Social support 2.30 1.00–5.31 0.05 1.01 0.56–1.79 0.98 0.99 0.60–1.63 0.98
25. Have trouble getting going 0.39 0.15–1.02 0.05 0.97 0.56–1.70 0.93 1.01 0.60–1.68 0.98
26. High blood pressure 0.88 0.44–1.74 0.71 1.02 0.67–1.55 0.94 0.93 0.63–1.37 0.71
27. Heart attack 1.19 0.61–2.32 0.61 0.58 0.38–0.90 0.02 1.24 0.85–1.80 0.26
28. CHF 2.25 1.17–4.33 0.02 1.22 0.77–1.92 0.40 0.96 0.66–1.41 0.84
29. Stroke 0.97 0.45–2.13 0.95 2.29 1.24–4.23 0.01 1.17 0.74–1.84 0.51
30. Cancer 2.93 1.61–5.35 0.00 0.96 0.60–1.53 0.85 1.91 1.30–2.81 0.00
31. Diabetes 0.93 0.53–1.65 0.80 0.88 0.61–1.27 0.49 1.18 0.86–1.62 0.31
32. Arthritis 0.63 0.32–1.22 0.17 1.29 0.87–1.91 0.21 0.65 0.45–0.95 0.02
33. Chronic lung disease 1.18 0.65–2.13 0.58 1.42 0.97–2.08 0.07 1.16 0.83–1.60 0.38
34. MMSE 0.90 0.41–1.99 0.80 1.04 0.69–1.56 0.86 1.11 0.75–1.65 0.61
35. BMI 0.85 0.44–1.64 0.63 0.83 0.53–1.30 0.41 0.76 0.52–1.12 0.16
36. Peak Expiratory Flow 2.42 1.10–5.21 0.03 1.06 0.70–1.58 0.79 1.51 1.01–2.27 0.05
37. Shoulder strength 0.54 0.27–1.08 0.08 1.32 0.89–1.96 0.17 1.08 0.75–1.57 0.67
38. Grip strength 2.56 1.13–5.82 0.02 1.56 1.04–2.35 0.03 1.28 0.85–1.92 0.23
39. Mini Nutritional Assessment 0.72 0.33–1.57 0.41 1.83 1.09–3.08 0.02 0.84 0.53–1.32 0.45
40. Rapid pace 2.00 1.06–3.80 0.03 1.59 1.08–2.34 0.02 1.15 0.82–1.61 0.43
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Successively, Rockwood and colleagues include 52 CGA 
components [56]. The CGA is used as a clinical standard 
for geriatric assessment and has been found to predict nega-
tive outcome in several kinds of patients with different dis-
eases [9, 57]. Thus, items from a standard routinely CGA 
may be combined with frailty score, and consequently, a 
risk stratification of future adverse outcomes may be rou-
tinely obtained. This approach is extremely positive when 
considering the “time consumption.” In fact, if “frailty 
index” is performed without CGA, the administration time 
is excessively extended. In contrast, when “frailty index” 
is performed after CGA, the administration time is signifi-
cantly comprised. In our protocol, IFi was performed after 
CGA takes less than 10 min.
Interestingly, CGA and frailty analysis are synergistic in 
predicting different outcomes. For mortality, the most pow-
erful item was “feel everything is an effort,” for disability 
was the history of stroke and for hospitalization was the 
presence of depression.
The integration of frailty measures in clinical practice
It is important that frailty is recognized in the clinical 
setting independently by the type of frailty measurement 
tool. Frailty is often included in the part of the normal 
aging process, and older patients are assessed on the basis 
of their medical conditions alone rather than accounting 
for their frailty status [58]. Thus, incorporating measure-
ment of frailty into clinical practice may provide a tool 
for clinicians to identify and preventively manage this 
condition [59]. As underlined before, the time consump-
tion seems to be the critical point of frailty measure-
ments. In fact, some authors tried to reduce the time con-
sumption by reducing the number of items used to assess 
frailty. Such approach often realizes shorter scales by 
reducing interpretability, generalizability or loss of useful 
information from the clinical point of view.
More importantly, the integration of frailty measures 
in clinical practice is essential for the improvement of 
interventions against age-related conditions, i.e., dis-
ability, in the elderly. Moreover, frailty is not only asso-
ciated with increased disability and mortality, but also 
with higher risk of cardiovascular, neurological and met-
abolic diseases [60–62]. In “Progetto Veneto Anziani” 
(Pro.V.A.) study that involved older community dwellers, 
pre-frailty and frailty are associated with an increased 
risk of cardiovascular diseases [60] and of incident type 
2 diabetes in the elderly [61]. Interestingly, among the 
physical domains of pre-frailty, low gait speed seems to 
be the best predictor of future cardiovascular diseases 
[61]. A recent meta-analysis indicates that frailty is a sig-
nificant predictor of incident Alzheimer’s disease, vas-
cular dementia and all dementia [62]. Finally, long.-term 
mortality in chronic obstructive pulmonary disease has 
been associated to severe clinical frailty [63].
At this regard, it should be underlined that the two 
principal tools to evaluate the frailty, “Fried’s frailty” 
and “frailty index,” should be considered complementary 
and not alternative [64]. “Fried’s frailty” exists even in 
the absence of nosographically classified conditions (i.e., 
disease) having as target older subjects in the absence of 
disability. In contrast, the frailty index is largely based 
on nosographically classified conditions having as target 
every any older subject also still experiencing disability. 
Thus, the Fried’s frailty phenotype may be more appro-
priate for an immediate identification of non-disabled 
elders at risk of negative events, while the “frailty index” 
may summarize the results of a CGA providing a marker 
of deficits accumulation that are present and concur at 
depleting endogenous reserves. However, when consid-
ering the outcomes, mortality and disability AUC curves 
for IFi present a good discriminatory value with respect 
Fig. 4  Receiver operating characteristics (ROC) curves of frailty 
index based on deficit in health (IFi) and Fried’s frailty index method 
on mortality (a), disability (considering the loss of 1 ADL vs. base-
line) (b) and hospitalization (c)
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to Fried’s frailty (0.809 vs. 0.658 and 0.800 vs. 0.729, 
respectively).
Limitations of the study
The present study presents at least two limitations. First of 
all, the study is not a multicenter study, and therefore, it did 
not include participant from different geographic locations 
with the impossibility to compare results among centers 
with different demographic factors. Secondly, the partici-
pants are out- and not in-hospital patients with a possible 
selection bias of the disease’s severity.
Conclusions
We conclude that IFi is a valid measure of frailty after 
CGA in an Italian cohort of non-institutionalized patients 
in predicting mortality, disability and hospitalization. IFi 
presents a good reliability, internal consistency and valid-
ity including all concepts of frailty (mental, physical, social 
and nutritional).
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Appendix 1
 
 
 
 
 
 
 
 
INDICE DI FRAGILITA’ 
 
 
___/40 
 
 
 
lieve (da 0.1 a 16.0); moderato (da 16.1 a 27.0); severo (da 27.1 a 40.0) 
 
 
 
UNIVERSITA’ DEGLI STUDI DI NAPOLI “FEDERICO II” 
Azienda Ospedaliera Univeristaria Federico II 
Dipartimento assistenziale ad attività integrata di 
MEDICINA CLINICA E PATOLOGIA CLINICA 
li, _____/_____/_____ 
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Paziente Cart. cl. Nato il__/__/__ Altezza = m Peso = Kg Tel. P
1. Aiuto nel lavarsi SI = 1 No = 0
2. Aiuto nel vestirsi SI = 1 No = 0
3. Aiuto nel sedersi o alzarsi 
dalla sedia
SI = 1 No = 0
4. Aiuto nel camminare in 
casa
SI = 1 No = 0
5. Aiuto nel mangiare SI = 1 No = 0
6. Aiuto nella cura della casa SI = 1 No = 0
7. Aiuto nell’utilizzare il 
bagno
SI = 1 No = 0
8. Aiuto nel salire o scendere 
le scale
SI = 1 No = 0
9. Aiuto nell’alzare 4.5 kg SI = 1 No = 0
10. Aiuto nel fare la spesa SI = 1 No = 0
11. Aiuto nei lavori di casa SI = 1 No = 0
12. Aiuto nel preparare i 
pasti
SI = 1 No = 0
13. Aiuto nell’assumere i 
farmaci
SI = 1 No = 0
14. Aiuto nella gestione del 
denaro
SI = 1 No = 0
15. Perdita di più di 4.5 kg di 
peso nell’ultimo anno
SI = 1 No = 0
16. Giudizio sulla propria 
salute
Scarsa = 1 Discreta = 0.75 Buona = 0.5 Molto buona = 0.25 Eccellente = 0
17. Come è cambiata la sua 
salute nell’ultimo anno?
Peggiorata = 1 Migliorata/stessa = 0
18. Persistenza a letto 
almeno 1/2 giornata 
per motivi di salute, 
nell’ultimo mese?
SI = 1 No = 0
19. Riduzione della solita 
attività nell’ultimo mese?
SI = 1 No = 0
20. Uscire <3 Giorni = 1 ≥3 Giorni = 0
21. Affaticarsi per qualsiasi 
cosa
Spesso = 1 Qualche volta = 0.5 Rara-
mente = 0
22. Sentirsi depresso Spesso = 1 Qualche volta = 0.5 Rara-
mente = 0
23. Sentirsi infelice Spesso = 1 Qualche volta = 0.5 Rara-
mente = 0
24. Social support score 
(vedi allegato 1)
>13 = 1 6–13 = 0.5 1–5 = 0
25. Avere difficoltà a met-
tersi in moto
Spesso = 1 Qualche volta = 0.5 Rara-
mente = 0
26. Ipertensione SI = 1 Sospetta = 0.5 No = 0
27.Angina pectoris SI = 1 Sospetta = 0.5 No = 0
28. Insufficienza cardiaca 
cronica
SI = 1 Sospetta = 0.5 No = 0
29. Ictus SI = 1 Sospetta = 0.5 No = 0
30. Cancro SI = 1 Sospetta = 0.5, No = 0
31. Diabete SI = 1 Sospetta = 0.5 No = 0
32. Artrosi SI = 1 Sospetta = 0.5 No = 0
33. Broncopneumopatia 
cronica
SI = 1 Sospetta = 0.5 No = 0
34. MMSE <10 = 1 11–17 = 0.75 18–20 = 0.5 20–24 = 0.25 >24 = 0
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Paziente Cart. cl. Nato il__/__/__ Altezza = m Peso = Kg Tel. P
35. BMI <18.5, ≥30 = 1 25–<30 = 0.5 18.5–
24.9 = 0
36. Picco flusso espira-
torio = _______L/min 
1 = ______ 2 = _______ 
3 = ______
≤340 (uomo), ≤310 
(donna) = 1
>340 (uomo), >310 
(donna) = 0
37. Forza muscolare solle-
vamento = Kg 1 = ______ 
2 = _______ 3 = ______
≤12 (uomo), ≤9 
(donna) = 1
>12 (uomo), >9 
(donna) = 0
38. Forza muscolare 
presa = Kg 1 = ______ 
2 = _______ 3 = ______
Uomo = 1 Uomo = 0
BMI ≤24, Kg ≤29 BMI ≤24 Kg >29
BMI 24.1–28 Kg ≤30 BMI 24.1–28 Kg >30
BMI >28 Kg ≤32 BMI >28 Kg >32
Donna = 1 Donna = 0
BMI ≤23 Kg ≤17 BMI ≤23 Kg >17
BMI 23.1–26 Kg ≤ 
17.3
BMI 23.1–26 Kg >17
BMI 26.1–29 Kg ≤18 BMI 26.1–29 Kg >18
BMI >29 Kg ≤21 BMI >29 Kg >21
39. Mini nutritional Assess-
ment (vedi allegato 2)
<17 = 1 17–23.5 = 0.5 24 = 0
40. Tempo impiegato per 
percorrere 4 metri con 
passo rapido (sec)
>10 = 1 ≤10 = 0
Totale
Scala supporto sociale
1. Stato civile Vedovo o celibe = 1 Coniugato = 0
2. Figli viventi No = 1 Sì = 0
3. Fratelli e sorelle viventi No = 1 Sì = 0
4. Frequenza di rapporti familiari Mai, raramente = 1 Spesso, di frequente = 0
5. Con chi abita Solo = 1 In compagnia = 0
6. Aiuto finanziario da parte dei familiari No = 1 Sì = 0
7. Rapporti stretti con parenti non familiari No = 1 Sì = 0
8. Aiuto concreto da parte dei familiari No = 1 Sì = 0
9. Con quante persone del vicinato si vede 
almeno una volta a settimana?
Nessuno = 1 Almeno una = 0
10. Ha amici intimi? No = 1 Sì = 0
11. Frequenza rapporti? Mai, raramente = 1 Spesso, di frequente = 0
12. Frequenta posti pubblici? Mai, raramente = 1 Spesso, di frequente = 0
13. Frequenta cinema-teatri? Mai, raramente = 1 Spesso, di frequente = 0
14. Frequenta associazioni di volontariato-
ricreative?
Mai, raramente = 1 Spesso, di frequente = 0
15. Legge i giornali? Mai, raramente = 1 Spesso, di frequente = 0
16. Ascolta radio e/o vede TV? Mai, raramente = 1 Spesso, di frequente = 0
17. Si prende cura dei bambini? Mai, raramente = 1 Spesso, di frequente = 0
Totale
Dalla analisi della tabella si ottiene uno score in cui i punteggi più alti individuano i soggetti con un basso livello di supporto sociale: il più basso 
livello si individua con un punteggio di 17
Supporto sociale buono: 1–5
Supporto sociale discreto: 6–13
Supporto sociale scarso: 14–17
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